BPL Medical Technologies delivered a strong presence at the 78th Annual Conference of IRIA 2026, where it showcased a range of advanced imaging, digital health, and AI-enabled radiology solutions. The company presented its latest product pipeline through expert-led launch sessions conducted alongside BPL’s leadership team, reflecting its focus on clinically relevant, India-ready technologies suited for real-world healthcare environments.
Strengthening its global imaging footprint, BPL Medical Technologies highlighted its acquisition of Yozma BMTech Co, Ltd (South Korea) completed in December 2025. The acquisition is expected to enhance BPL’s precision imaging capability and accelerate integration of global technologies into India’s diagnostic ecosystem.
During the conference, the company also introduced BMTech in the presence of industry expert Mr Govindarajan, Founder & CEO of Aarthi Scans, underlining the importance of global technology partnerships in raising diagnostic standards. The sessions also addressed women’s health imaging, with a special focus on advancements in bone densitometry and mammography.
Expanding its AI suite, BPL unveiled BPL Cortex, an AI-driven radiology platform designed to support clinical decision-making, reduce workflow bottlenecks, and improve reporting turnaround. BPL also announced a partnership with 5C Network, India’s AI-first radiology platform, to jointly develop an OEM-embedded AI solution for imaging systems—positioned as a first-of-its-kind initiative in India.
Another highlight of BPL’s participation was RIA, the company’s robotic assistant, which hosted multiple expert-led educational sessions across imaging, women’s health, and AI applications in radiology. The sessions saw high delegate participation, indicating rising interest in structured, technology-led diagnostic learning.
Commenting on the company’s participation, Dr Shravan Subramanyam, Managing Director, BPL Medical Technologies, said, “IRIA gives us a direct opportunity to engage with the radiology community. Our effort is centred on building integrated imaging and AI solutions that improve diagnostic confidence, while remaining scalable, practical, and accessible for India’s healthcare system.”
BPL Medical Technologies’ participation at IRIA 2026 reinforced its commitment to driving innovation in imaging and radiology through solutions that combine clinical value with advanced engineering. Founded in 2013, BPL Medical Technologies is India’s leading homegrown medical equipment company, offering solutions across cardiology, critical care, imaging, and home healthcare. The company carries forward the legacy of BPL (British Physical Laboratories), founded in 1967, which pioneered India’s first ECG machine.
BPL designs and manufactures a wide portfolio of Made-in-India medical devices, including patient monitors, ventilators, ultrasound and X-ray systems, digital health solutions, and consumer health products. With 14 regional offices and a workforce of more than 500 professionals, BPL serves healthcare providers across both urban and rural India.
The company has reported a 16.9% CAGR between 2014 and 2024, and is targeting 32% growth in the next fiscal year. BPL has received multiple recognitions, including Best Healthcare Brand (The Economic Times) and Most Leading Brand in Medical Equipment (Medgate Today). The company is backed by Claypond Capital, the family office of Ranjan Pai.
